Melinta Therapeutics, Inc.
(NASDAQ : MLNT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
MDCOMedicines Company
0.13%48.2520.3%$147.48m
VRXValeant Pharmaceuticals International, Inc.
-0.09%23.1314.1%$136.10m
AMRNAmarin Corporation Plc Sponsored ADR
0.89%17.091.8%$99.12m
JAZZJazz Pharmaceuticals Plc
1.57%131.282.3%$63.69m
PRGOPerrigo Co. Plc
2.80%55.826.8%$62.04m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-1.84%132.436.2%$60.04m
SAGESAGE Therapeutics, Inc.
-0.78%162.328.6%$57.23m
CTLTCatalent Inc
1.51%51.412.4%$41.73m
UTHRUnited Therapeutics Corporation
-0.56%85.4414.3%$36.48m
MNKMallinckrodt Plc
4.10%2.5420.9%$35.90m
ENDPEndo International Plc
5.51%3.558.8%$35.64m
ICPTIntercept Pharmaceuticals, Inc.
0.04%69.2816.9%$30.95m
AERIAerie Pharmaceuticals, Inc.
-0.52%22.796.8%$28.61m
ICLRICON Plc
1.05%154.784.1%$28.35m
PTLAPortola Pharmaceuticals, Inc.
0.53%30.386.7%$26.49m

Company Profile

Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ.